You are looking for

Tonight, Brazil and Croatia will kick off what promises to be a great month for football fans the world over. And what will make it extra special for us in the MedTech industry is that the first kick will be given by a paralysed teenager. This remarkable feat is made possible thanks to an exo-skeleton […]

For a 3rd year in a row PatientView has published its study on “The corporate reputation of the medical device industry – from the patient perspective”. As in the past the reputation of the medical device industry and specific companies are measured by hundreds of patient groups from all over the world. In the latest […]

“How much is my life worth?” Patricia Garcia-Prieto, professor of Organisational Behaviour at the Solvay Brussels School of Economics and Management and a mother of six and 11-year olds has asked this question multiple times. In her video, as a patient representative on a panel, she has been vocal about this thought that passed her mind every day. […]

As AdvaMed and Eucomed prepare for our next Global MedTech Compliance Conference May 20-22, 2014 in Barcelona, Spain, I reflect on the remarkable policy outcomes attributed to our past conference discussions.  Our MedTech association-led compliance conferences offer a platform—not available in a commercial compliance conference—to spur discussion and best practices exchange among compliance leaders on […]

Safe and accurate In Vitro Diagnostics (IVDs) are essential to a safe, efficient and effective healthcare system. Policymakers recognise this and that’s why they have included a clinical evidence requirement in the upcoming revision of the IVD Directive (IVDD). Because IVDs play such a pivotal role in the treatment pathway of patients, we, the IVD […]

The work we do at the Helen Hamlyn Centre for Design at the Royal College of Art in London focuses on developing projects with a strong emphasis on identifying and understanding everyday situations that people have difficulty with.  Our approach is inclusive: we work with many ‘users’ of a product, service or system in order […]

“Nihil novi sub sole” said the Vulgate. That could not be farther from reality when it comes to the MedTech Europe blog. And I am privileged to be the first author to “lay pen to paper” and contribute to MedTech Views, an initiative by MedTech Europe to establish a true platform for dialogue about medical technologies. No priority is given to any one healthcare stakeholder, and everyone has the opportunity to submit their view as we strive to have an open exchange of opinions on the new platform.

Access to quality healthcare and medical technologies has risen to the top of the international health agenda. In this regard, diabetes is a particular challenge as good management relies on continuous access to both medicines and medical devices. In its latest study, IDF Europe found that hundreds of thousands of people living with diabetes in Europe do not have access to the treatment they need, putting their health at risk.

The year is nearing its end and as I look at the christmas tree being put up, the smell of pinewood slowly filling our office’s reception area, I cannot help but think that 2013 was a crucial year for patients, healthcare systems and Europe as a whole. This past year was dominated by one topic of mastodont proportions, but other actions, activities and achievements have been just as important to us.